Congratulations to cc-TDI lab member, Noah Berlow PhD, whose cc-TDI spinout company, First Ascent, recently won a Portland-area startup challenge award!

Some big news about tiny molecules: cc-TDI has recently been awarded an AIMS Award from Atomwise to create a molecularly-designed new drug for EWSR1 fusion

We are thrilled to announce the latest addition to our board of directors: Sharleigh Stevenson is President of the Australian non-profit Braver Stronger Smarter Incorporated and has been

Our research on Clear Cell Sarcoma (CCS) now includes an international collaboration.  We have received samples from nearly every continent to study, but we have

We have some bright news for your Wednesday: The Gabriella Miller Kids First Research Act 2.0 is a bipartisan bill, which proposes that penalties from

We are thinking back to the recent past when we could have visitors in the lab and hopeful we can return to that mode someday

Even in this time of extreme uncertainty, particularly in healthcare, parents are still hearing the words: “your child has cancer” every single day. Cancer doesn’t

While much of the workforce is now working from home, we are excited to partner with IBM research. Folks who want to directly help cc-TDI

While much of the workforce is now working from home, you can join cc-TDI and IBM research! Do you want to directly help cc-TDI develop

We are excited to welcome Dr. Andrew Watson, Ph.D., C.L.P. to the cc-TDI Scientific Advisory Board. Dr. Watson is the Senior Director of the Oregon